Publications
- Adalimumab versus infliximab in pediatric patients with Crohn's disease: A propensity-score analysis and predictors of treatment escalation2022 | Second Faculty of Medicine
- Sustainability of biologic treatment in paediatric patients with Crohn's disease: population-based registry analysis2024 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease2023 | Second Faculty of Medicine
- Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study2021 | First Faculty of Medicine, Second Faculty of Medicine
- Microbial shifts of faecal microbiota using enteral nutrition in vitro2021 | Second Faculty of Medicine
- Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease2021 | Second Faculty of Medicine
- Novel SAMD9 Mutation in a Patient With Immunodeficiency, Neutropenia, Impaired Anti-CMV Response, and Severe Gastrointestinal Involvement2019 | First Faculty of Medicine, Second Faculty of Medicine
- The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease2019 | Second Faculty of Medicine
- Enteral Nutrition as a Growth Medium for Cultivable Commensal Bacteria and Its Effect on Their Quantity in the Stool of Children with Crohn's Disease2019 | Second Faculty of Medicine
- Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease2018 | Second Faculty of Medicine
Loading network view...